Tim (Hrsg.) Cross

Liver Cancers

From Mechanisms to Management

Ebook (PDF Format)

This book explores in detail the primary liver cancers of hepatocellular carcinoma and cholangiocarcinoma examining the pathogenesis of disease along with diagnosis and current management options together with exploration of future treatment strategies and areas of controversy. Furthermore, the book also highlights management of the common secondary malignancies and touches on benign liver tumours and how to best manage these. Written in a clear and didactic style, this volume includes summaries of the key learning points and questions so that the reader can gauge their knowledge and understanding.This book is aimed to broaden the knowledg… Mehr

CHF 141.50

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen
Versandkostenfrei

Produktdetails

Weitere Autoren: Palmer, Daniel H. (Hrsg.)

ISBN: 978-3-319-92216-4
EAN: 9783319922164
Produktnummer: 29508941
Verlag: Springer-Verlag GmbH
Sprache: Englisch
Erscheinungsjahr: 2018
Seitenangabe: 312 S.
Plattform: PDF
Masse: 7'081 KB
Auflage: 1st ed. 2019
Abbildungen: 12 schwarz-weiße und 34 farbige Abbildungen, Bibliographie

Über den Autor

Dr Tim Cross, BMedSci (Hons), MB BS, MD, FRCP Dr Cross qualified from St. Bartholomew's hospital medical college in 1996. He undertook general gastroenterology training in North East London and hepatology training at Addenbrookes hospital, Cambridge, The Royal Free Hospital, University College Hospital and Kings College Hospital, London. He was a consultant at the South West Liver Unit, Plymouth UK before moving to the Royal Liverpool Hospital in 2012. Prof Daniel Palmer, BSc (Hons), MBChB, PhD, FRCP Professor Palmer graduated from the University of Birmingham in 1995 and undertook his specialist training in Medical Oncology in the Birmingham Oncology Centre before taking the position of Cancer Research UK Clinician Scientist and Senior Lecturer, University of Liverpool. He took the North West Cancer Research Chair of Medical Oncology at the University of Liverpool in 2011. His specialist interests include development of novel therapies and clinical trials for hepatobiliary and pancreatic cancers.